Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries: Results from the multicenter american research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (MARCATOR)

Journal of the American College of Cardiology

Volumn 27, Issue 1, 1996, Pages 1-7

  Berger, Peter B ^a   Holmes Jr , David R ^a   Ohman, E Magnus ^b   O'Hanesian, Mary Ann ^b   Murphy, Joseph G ^a   Schwartz, Robert S ^a   Serruys, Patrick W ^c   Faxon, David P ^d  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILAZAPRIL; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030040221     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00439-4     Document Type: Article

References (20)

1. Bell MR, Berger PB, Bresnahan JF, Reeder GS, Bailey KR, Holmes DR Jr. Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary artery occlusions. Circulation 1992;85:1003-11.
2. Ellis SG, Shaw RE, Gershony G, et al. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion. Am J Cardiol 1989;63:897-901.
3. Stone GW, Rutherford BD, McConahay DR, et al. Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients. J Am Coll Cardiol 1990;61:23G-8G.
4. Ivanhoe RJ, Weintraub WS, Douglas JS Jr., et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions: primary success, restenosis, and long-term clinical follow-up. Circulation 1992;85:106-15.
5. Serruys PW, Umans V, Heyndrickx GR, et al. Elective PTCA of totally occluded coronary arteries not associated with acute myocardial infarction: short-term and long-term results. Eur Heart J 1985;6:2-12.
6. Kereiakes DJ, Selmon MR, McAuley BJ, McAuley DB, Sheehan DJ, Simpson JB. Angioplasty in total coronary artery occlusion: experience in 76 consecutive patients. J Am Coll Cardiol 1985;6:526-33.
7. Dervan J, Baim DS, Cherniles J, Grossman W. Transluminal angioplasty of occluded coronary arteries: use of a movable guide wire system. Circulation 1983;68:776-84.
8. DiSciascio G, Vetrovec GW, Cowley MJ, Wolfgang TC. Early and late outcome of percutaneous transluminal coronary angioplasty for subacute and chronic total coronary occlusion. Am Heart J 1986;111:833-9.
9. Haine E, Urban P, Dorsaz PA, Meier B. Outcome and complications of 500 consecutive chronic total occlusion angioplasties [abstract]. J Am Coll Cardiol 1993;21:138A.
10. Melchior JP, Meier B, Urban P, et al. Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. Am J Cardiol 1987;59:535-8.
11. Warren RJ, Black AJ, Valentine PA, Manolas EG, Hunt D. Coronary angioplasty for chronic total occlusion reduces the need for subsequent coronary bypass surgery. Am Heart J 1990;120:270-4.
12. Ryan TJ, Klocke FJ, Reynolds WA. Clinical competence in percutaneous transluminal coronary angioplasty: a statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. J Am Coll Cardiol 1990;15:1469-74.
13. Violaris AG, Melkert R, Serruys PW. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis. Circulation 1995;91:2140-50.
14. Faxon DP, on behalf of the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;25:362-9.
15. Kuntz BE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993;88:1310-23.
16. Serruys PW, Foley DP, Kirkeeide RL, King SB III. Restenosis revisited: insights provided by quantitative coronary angiography [editorial]. Am Heart J 1993;126:1243-67.
17. The Multicenter European Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992;86:100-10.
18. Bell MR, Menke KK, Berger PB, Holmes DR Jr. Balloon angioplasty of chronic total coronary occlusions: what does it cost in radiation exposure, time and materials? Cathet Cardiovasc Diagn 1992;25:10-5.
19. Hsu Y-S, Tamai H, Udeda K, et al. Clinical efficacy of coronary stenting in chronic total occlusions [abstract]. Circulation 1994;90(Pt 2):I-613A.
20. Ooka M, Suzuki T, Hosokawa H, et al. Stenting vs. non-stenting after revascularization of chronic total occlusion [abstract]. Circulation 1994;90(Pt 2):I-613A.